Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Obstetrics and Gynecology
|
December 13, 2012
Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers
Janice S Kwon, Anna Tinker, Gary Pansegrau, et al.
Gynecologic Oncology
|
July 5, 2005
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma
David M O'Malley, Masoud Azodi, Anita Makkenchery, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 24, 2013
Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists
Clare J Reade, Sarah Finlayson, Jessica McAlpine, et al.
Gynecologic Oncology
|
September 3, 2018
Does MMR status in endometrial cancer influence response to adjuvant therapy?
Soyoun Rachel Kim, Annick Pina, Arianne Albert, et al.
Molecular Cancer Research : MCR
|
August 19, 2008
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer
Yi Zhou, Xiaofang Yi, Jha'nae B Stoffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently?
Michael L Friedlander, Martin Richard Stockler, Phyllis Butow, et al.
Gynecologic Oncology
|
July 12, 2005
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy
Michael G Kelly, David M O'malley, Pei Hui, et al.
Gynecologic Oncology
|
October 19, 2013
Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival
Brandon Bernard, Blaise A Clarke, Janet I Malowany, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
Brain metastases in epithelial ovarian and primary peritoneal carcinoma
Elena S Ratner, Eugene Toy, David M O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma
James P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Obstetrics and Gynecology
|
December 13, 2012
Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers
Janice S Kwon, Anna Tinker, Gary Pansegrau, et al.
Gynecologic Oncology
|
July 5, 2005
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma
David M O'Malley, Masoud Azodi, Anita Makkenchery, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 24, 2013
Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists
Clare J Reade, Sarah Finlayson, Jessica McAlpine, et al.
Gynecologic Oncology
|
September 3, 2018
Does MMR status in endometrial cancer influence response to adjuvant therapy?
Soyoun Rachel Kim, Annick Pina, Arianne Albert, et al.
Molecular Cancer Research : MCR
|
August 19, 2008
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer
Yi Zhou, Xiaofang Yi, Jha'nae B Stoffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently?
Michael L Friedlander, Martin Richard Stockler, Phyllis Butow, et al.
Gynecologic Oncology
|
July 12, 2005
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy
Michael G Kelly, David M O'malley, Pei Hui, et al.
Gynecologic Oncology
|
October 19, 2013
Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival
Brandon Bernard, Blaise A Clarke, Janet I Malowany, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
Brain metastases in epithelial ovarian and primary peritoneal carcinoma
Elena S Ratner, Eugene Toy, David M O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma
James P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Page
of 3